Chembio Diagnostics, FIND to develop HCV POC diagnostic test
World | News | 0 Comment | 30 Jul, 2018
Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic testing, has announced a collaboration with the Fo...Read more
Siemens Healthineers launches heart attack diagnostic tests
World | News | 0 Comment | 27 Jul, 2018
Siemens Healthineers has introduced two new assays for quick diagnosis of acute myocardial infarction or heart attack, f...Read more
Merck’s formulation steps further for approval in 21 EU countries
World | News | 0 Comment | 26 Jul, 2018
Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...Read more
XLerateHealth Accelerator selects ten companies for incoming sixth cohort
World | News | 0 Comment | 26 Jul, 2018
XLerateHealth, an enterprise-focused healthcare accelerator that helps early-stage healthcare companies has announced it...Read more
GSK signs $300M genetic testing deal
World | News | 0 Comment | 26 Jul, 2018
Singapore- GlaxoSmithKline has made a $300 million equity investment in the Silicon Valley gene testing compan...Read more
NanoSphere receives patent for nanoparticle delivery of Cannabis
World | News | 0 Comment | 25 Jul, 2018
NanoSphere Health Sciences has been awarded a breakthrough patent, granting the biotech innovator full ownership over th...Read more
AstraZeneca sells European rights for heart failure treatment for $210M
World | News | 0 Comment | 24 Jul, 2018
Singapore - AstraZeneca has agreed to sell the European commercial rights to hypertension and heart...Read more
Biocept, UC collaborate on predicting disease recurrence in solid tumors
World | News | 0 Comment | 24 Jul, 2018
Singapore - Biocept, a leading commercial provider of liquid biopsy tests designed to provide physicians with clin...Read more
Tabula Rasa HealthCare’s SinfoníaRx releases RxCompanion 10.0 Software
World | News | 0 Comment | 24 Jul, 2018
Tabula Rasa HealthCare, Inc., a healthcare technology company optimizing medication safety has announced a new generatio...Read more
FDA approves Tibsovo for AML patients
World | News | 0 Comment | 23 Jul, 2018
Singapore – The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) tablets for the treatment of adult...Read more
Agios receives nod for ivosidenib
World | News | 0 Comment | 23 Jul, 2018
Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...Read more
Bayer to stop Essure sales at year-end
World | News | 0 Comment | 23 Jul, 2018
Singapore –Bayer AG will no longer sell its controversial female contraceptive implant Essure after December 31. T...Read more
FDA approves Pfizer's biosimilar
World | News | 0 Comment | 23 Jul, 2018
Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected t...Read more
Allergan strikes out with sovereign nation scheme to protect patents
World | News | 0 Comment | 23 Jul, 2018
Singapore – The U.S. Court of Appeals has affirmed the decision of the USPTO's Patent Trial and Appeal B...Read more
Azafaros to develop new treatments for rare metabolic disorders
World | News | 0 Comment | 23 Jul, 2018
Azafaros, a spin-off from Leiden University and Amsterdam UMC, focusing on the development of new therapies in the field...Read more
UK Government hosts roundtables with stakeholders from key life science businesses
World | News | 0 Comment | 23 Jul, 2018
The UK Government, last week, hosted the second in a series of roundtables with stakeholders from key life science busin...Read more
Kite announces collaboration with Gadeta
World | News | 0 Comment | 23 Jul, 2018
Kite, a Gilead Company and Gadeta B.V., a privately-held company focused on the discovery and development of novel cance...Read more
J&J sells global rights of SYLVANT to EUSA Pharma
World | News | 0 Comment | 21 Jul, 2018
EUSA Pharma (EUSA), a biopharmaceutical company focused on oncology and rare disease, has entered into a definitive agre...Read more